Vascular activities of endothelin-1 and some alanyl substituted analogues in resistance beds of the rat

British Journal of Pharmacology

Volumn 98, Issue 2, 1989, Pages 685-699

  Randall, M D ^a   Douglas, S A ^a   Hiley, C R ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ENDOTHELIN 1; ENDOTHELIN 1 [1,15 ALANINE]; ENDOTHELIN 1 [1,3,11,15 ALANINE]; ENDOTHELIN 1 [3,11 ALANINE]; INDOMETACIN; METHOXAMINE; NORADRENALIN; PHENYLEPHRINE;

ANIMAL EXPERIMENT; ENDOTHELIUM; HINDLIMB; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MESENTERY BLOOD FLOW; NONHUMAN; PERFUSION; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; VASOCONSTRICTION; VASODILATATION;

EID: 0024461586     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1989.tb12644.x     Document Type: Article

References (41)

1. ACEVES, J., MARISCAL, S., MORRISON, K.E. & YOUNG, J.M. (1985). The binding of doxepin to histamine H 1 ‐receptors in guinea‐pig and rat brain. Br. J. Pharmacol., 84, 417–424.
2. ANGGARD, E., GALTON, S., RAE, G., THOMAS, R., McGLOUGHLIN, L., DE NUCCI, G. & VANE, J.R. (1989). The fate of radioiodinated endothelin‐1 and endothelin‐3 in the rat. J. Cardiovasc. Pharmacol., 13 (suppl. 5), S46–S49.
3. BRAIN, S.D., TIPPINS, J.R. & WILLIAMS, T.J. (1988). Endothelin induces potent microvascular constriction. Br. J. Pharmacol., 95, 1005–1007.
4. DE NUCCI, G., THOMAS, R., D'ORLEANS‐JUSTE, P., ANTONES, E., WALDER, C., WARNER, T.D. & VANE, J.R. (1988). Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium‐derived relaxing factor. Proc. Natl. Acad. Sci. U.S.A., 85, 9797–9800.
5. D'ORLEANS‐JUSTE, P., ANTONES, E., DE NUCCI, G. & VANE, J.R. (1988). A profile of endothelin on isolated vascular and other smooth muscle preparations. Br. J. Pharmacol., 95, 809P.
6. GARDINER, S.M., COMPTON, A.M., BENNETT, T. & BLOOM, S.R. (1989). Regional haemodynamic effects of porcine endothelin in conscious Wistar rats. J. Cardiovasc. Pharmacol., 13 (suppl. 5), S202–S204.
7. HILEY, C.R., NICHOLS, A.J. & WILSON, A.C. (1985). Effects of phenobarbitone and 6‐methylprednisolone pretreatment on pressure/flow relations in the rat superior mesenteric and iliac arterial beds of the rat. J. Pharm. Pharmacol., 37, 164–169.
8. HILEY, C.R., PHOON, C.K.L. & THOMAS, G.R. (1987). Acetylcholine vasorelaxation in the superior mesenteric bed of the rat is endothelium‐dependent and sensitive to antioxidants. Br. J. Pharmacol., 91, 376P.
9. HILEY, C.R., DOUGLAS, S.A. & RANDALL, M.D. (1989a). Pressor effects of endothelin‐1 and some analogs in the perfused superior mesenteric arterial bed of the rat. J. Cardiovasc. Pharmacol., 13 (suppl. 5), S197–S199.
10. HILEY, C.R., PELTON, J.T. & MILLER, R.C. (1989b). Effects of endothelin on field stimulated rat vas deferens and guinea‐pig ileum. Br. J. Pharmacol., 96, 104P.
11. INOUE, A., YANAGISAWA, M., KIMURA, S., KASUYA, Y., MIYAUCHI, T., GOTO, K. & MASAKI, T. (1989). The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc. Natl. Acad. Sci. U.S.A., 86, 2863–2867.
12. JACKSON, E.K. & CAMPBELL, W.B. (1980). The in situ blood perfused rat mesentery; a model for assessing modulation of adrenergic transmission. Eur. J. Pharmacol., 66, 217–224.
13. JONES, C.R., HILEY, C.R., PELTON, J.T. & MILLER, R.C. (1989a). Autoradiographic localisation of endothelin binding sites in kidney. Eur. J. Pharmacol., 163, 379–382.
14. JONES, C.R., HILEY, C.R., PELTON, J.T. & MOHR, M. (1989b). Autoradiographic visualization of the binding sites for [ 125 I]endothelin in rat and human brain. Neurosci. Lett., 97, 276–279.
15. JONES, C.R., PELTON, J.T., MILLER, R.C. & HILEY, C.R. (1989c). Binding of [ 125 I]endothelin to rat brain and its inhibition by peptide analogues. Br. J. Pharmacol., 96, 346P.
16. KIMURA, S., KASUYA, Y., SAWAMURA, T., SHINMI, O., SUGITA, Y., YANAGISAWA, M., GOTO, K. & MASAKI, T. (1988). Structure‐activity relationships of endothelin: importance of the C‐terminal moiety. Biochem. Biophys. Res. Commun., 156, 1182–1186.
17. KLOOG, Y., ÁMBAR, I., SOKOLOVSKY, M., KOCHVA, E., WULLBERG, Z. & BDOLAH, A. (1988). Sarafotoxin, a novel vasoconstrictor peptide: phosphoinositide hydrolysis in rat heart and brain. Science, 242, 268–270.
18. KOMURO, I., KURIHARA, H., SUGIYAMA, T., TAKAKU, F. & YAZAKI, Y. (1988). Endothelin stimulates c‐fos and c‐myc expression and proliferation of vascular smooth muscle cells. FEBS Lett., 238, 249–252.
19. MACNAUGHTON, W.K., KEENAN, C.M., McKNIGHT, G.W. & WALLACE, J.L. (1989). The modulation of gastric mucosal integrity of endothelin‐1 and prostacyclin. J. Cardiovasc. Pharmacol., 13 (suppl. 5), S118–S122.
20. MACLEAN, R.R., RANDALL, M.D. & HILEY, C.R. (1989). Effects of moderate hypoxia, hypercapnia and acidosis on haemodynamic changes induced by endothelin‐1 in the pithed rat. Br. J. Pharmacol., (in press).
21. McGREGOR, D.D. (1965). The effect of sympathetic nerve stimulation on vasoconstrictor responses in perfused mesenteric blood vessels of the rat. J. Physiol., 177, 21–30.
22. NEUSER, D., STEINKE, W., THEISS, G. & STASCH, J. P. (1989). Autoradiographic localization of [ 125 I]‐endothelin‐1 and [ 125 I]atrial natriuretic peptide in rat tissue: a comparative study. J. Cardiovasc. Pharmacol., 13 (suppl. 5), S67–S73.
23. POHL, U. & BUSSE, R. (1989). Differential vascular sensitivity to luminally and adventitially applied endothelin‐1. J. Cardiovasc. Pharmacol., 13 (suppl. 5), S188–S190.
24. RAE, G.A., TRYBULEC, M., DE NUCCI, G. & VANE, J.R. (1989). Endothelin‐1 releases eicosanoids from rabbit isolated perfused kidney and spleen. J. Cardiovasc. Pharmacol., 13 (suppl. 5), S89–S92.
25. RANDALL, M.D. (1989). Activities of endothelium‐derived vasoactive factors in resistance beds of the rat. Ph.D. Thesis. University of Cambridge.
26. RANDALL, M.D. & HILEY, C.R. (1988). Detergent and methylene blue affect endothelium‐dependent vasorelaxation and pressure/flow relations in rat blood perfused mesenteric arterial bed. Br. J. Pharmacol., 95, 1081–1088.
27. RANDALL, M.D., SMITH, B.H.E. & HILEY, C.R. (1988). Effects of endothelium destruction in vitro and in situ on noradrenaline pressor responses in rat superior mesenteric arterial bed. Br. J. Pharmacol., 95, 816P.
28. SHIBA, R., YANAGISAWA, M., MIYAUCHI, T., KIMURA, S., UCHIYAMA, Y., MASAKI, T. & GOTO, K. (1989). Elimination of intravenously injected endothelin‐1 from the circulation of the rat. J. Cardiovasc. Pharmacol., 13 (suppl. 5), S98–S101.
29. SPOKES, R.A., GHATEI, M.A. & BLOOM, S.R. (1989). Studies with endothelin‐3 and endothelin‐1 on rat blood pressure and isolated tissues: evidence for multiple endothelin receptor subtypes. J. Cardiovasc. Pharmacol., 13 (suppl. 5), S191–S192.
30. TAKAGI, M., MATSUOKA, H., ATARASHI, K. & YAGI, S. (1988). Endothelin: a new inhibitor of renin release. Biochem. Biophys. Res. Commun., 157, 1164–1168.
31. THIEMERMANN, C., LIDBURY, P., THOMAS, R. & VANE, J. (1988). Endothelin inhibits ex vivo platelet aggregation in the rabbit. Eur. J. Pharmacol., 158, 181–182.
32. THOMAS, G.R., WALDER, C., THIEMERMANN, C. & VANE, J.R. (1989). Effect on endothelin on cardiac output and regional blood flow in the pithed rat. Br. J. Pharmacol., 96, 166P.
33. TOPOUZIS, S., PELTON, J.T. & MILLER, R.C. (1989). Contractile effects of endothelin and [Ala 3,11 ]endothelin in rat isolated aorta. Br. J. Pharmacol., 96, 101P.
34. TURNER, N.C., POWER, R.F., POLAK, J.M., BLOOM, S.R. & DOLLERY, C.T. (1989). Contraction of rat tracheal smooth muscle by endothelin. Br. J. Pharmacol., 96, 103P.
35. WALDER, C.E., THOMAS, G.R., THIEMERMANN, C. & VANE, J.R. (1989). The haemodynamic effects of endothelin‐1 in the pithed rat. J. Cardiovasc. Pharmacol., 13 (suppl. 5), S93–S97.
36. WALLACE, J.L., CIRINO, G., DE NUCCI, G., MCKNIGHT, W. & MACNAUGHTON, W.K. (1989). Endothelin has potent ulcerogenic and vasoconstrictor actions in the stomach. Br. J. Pharmacol., 96, 96P.
37. WARNER, T., DE NUCCI, G. & VANE, J.R. (1989). Rat endothelin is a vasodilator in the isolated perfused isolated mesentery of the rat. Eur. J. Pharmacol., 159, 325–326.
38. WHITTLE, B.J.R., PAYNE, A.N. & ESPLUGUES, J.V. (1989). Cardiopulmonary and gastric ulcerogenic actions of endothelin‐1 in the guinea pig and rat. J. Cardiovasc. Pharmacol., 13 (suppl. 5), S103–S107.
39. WRIGHT, C.E. & FOZARD, J.R. (1988). Regional vasodilatation is a prominent feature of the haemodynamic response to endothelin in anaesthetised spontaneously hypertensive rats. Eur. J. Pharmacol., 155, 201–203.
40. YANAGISAWA, M., KURIHARA, H., KIMURA, S., TOMOBE, Y., KOBAYASHI, M., MITSUI, Y., YAZAKI, Y., GOTO, K. & MASAKI, M. (1988). A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature, 332, 411–415.
41. YOSHIZAWA, T., KIMURA, S., KANAZAWA, I., YANAGISAWA, M. & MASAKI, T. (1989). Endothelin‐1 depolarizes a ventral root potential in the newborn rat spinal cord. J. Cardiovasc. Pharmacol., 13 (suppl. 5), S216–S217.